I will also add that, much like the remainder of the US fee-for-service and for-profit healthcare system, medication prices are artificially inflated to allow for the price to be negotiated down by insurance agencies, but there are no guarantees distributors, whether retail or clinic-based, will be able to provide similar relief to the uninsured or underinsured. This leaves a variable "cash price" often based on arbitrary markups from the best wholesale price the distributor can procure.
I will also add that, much like the remainder of the US fee-for-service and for-profit healthcare system, medication prices are artificially inflated to allow for the price to be negotiated down by insurance agencies, but there are no guarantees distributors, whether retail or clinic-based, will be able to provide similar relief to the uninsured or underinsured. This leaves a variable "cash price" often based on arbitrary markups from the best wholesale price the distributor can procure.